Bernzott Capital Advisors Amgen Inc Transaction History

Bernzott Capital Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $244,212 - $275,317	-1,318 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $1,992 - $2,238	12 Added 0.92%	1,318 $243,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $677 - $792	-4 Reduced 0.31%	1,306 $223,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $219,149 - $250,210	1,310	1,310 $244,000

2,959

402M

6.59M

6.61M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $177B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Bernzott Capital Advisors with notifications on news.